A citation-based method for searching scientific literature

J Brandt, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian. JAMA 1989
Times Cited: 124







List of co-cited articles
547 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A polymorphic DNA marker genetically linked to Huntington's disease.
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
53

The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
345
48

Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
181
42

Predictive testing for Huntington's disease with use of a linked DNA marker.
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
154
41



Uptake of presymptomatic predictive testing for Huntington's disease.
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
180
32



Attitudes of persons at risk for Huntington disease toward predictive testing.
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
157
27

Attitudes toward presymptomatic testing in Huntington disease.
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
127
23




On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
95
16

Problems in genetic prediction for Huntington's disease.
M J Morris, A Tyler, L Lazarou, L Meredith, P S Harper. Lancet 1989
41
39

Understanding the decision to take the predictive test for Huntington disease.
G J Meissen, C A Mastromauro, D K Kiely, D S McNamara, R H Myers. Am J Med Genet 1991
52
30

Self-selection in predictive testing for Huntington's disease.
A M Codori, R Hanson, J Brandt. Am J Med Genet 1994
114
14



Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
83
15


The measurement of abnormal movement: methods developed for Huntington's disease.
S E Folstein, B Jensen, R J Leigh, M F Folstein. Neurobehav Toxicol Teratol 1983
160
12

Improved predictive testing for Huntington disease by using three linked DNA markers.
M R Hayden, C Robbins, D Allard, J Haines, S Fox, J Wasmuth, M Fahy, M Bloch. Am J Hum Genet 1988
51
23

Trinucleotide repeat length instability and age of onset in Huntington's disease.
M Duyao, C Ambrose, R Myers, A Novelletto, F Persichetti, M Frontali, S Folstein, C Ross, M Franz, M Abbott. Nat Genet 1993
799
12



Predictors of psychological adjustment to genetic testing for Huntington's disease.
A M Codori, P R Slavney, C Young, D L Miglioretti, J Brandt. Health Psychol 1997
64
17

DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects.
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
74
14



Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
59
18




Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
103
10

Proceed with care: direct predictive testing for Huntington disease.
C M Benjamin, S Adam, S Wiggins, J L Theilmann, T T Copley, M Bloch, F Squitieri, W McKellin, S Cox, S A Brown. Am J Hum Genet 1994
81
12

A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.
B Kremer, P Goldberg, S E Andrew, J Theilmann, H Telenius, J Zeisler, F Squitieri, B Lin, A Bassett, E Almqvist. N Engl J Med 1994
414
10

Discrimination as a consequence of genetic testing.
P R Billings, M A Kohn, M de Cuevas, J Beckwith, J S Alper, M R Natowicz. Am J Hum Genet 1992
318
10

The measurement of pessimism: the hopelessness scale.
A T Beck, A Weissman, D Lester, L Trexler. J Consult Clin Psychol 1974
10

Testing for Huntington's disease with support for all parties.
A Tibben, M Vegter-vd Vlis, M F vd Niermeijer, J J Kamp, R A Roos, H G Rooijmans, P G Frets, F Verhage. Lancet 1990
41
24

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.
S E Andrew, Y P Goldberg, B Kremer, H Telenius, J Theilmann, S Adam, E Starr, F Squitieri, B Lin, M A Kalchman. Nat Genet 1993
783
10


One hundred requests for predictive testing for Huntington's disease.
S A Simpson, J Besson, D Alexander, K Allan, A W Johnston. Clin Genet 1992
37
24

Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment.
S Adam, S Wiggins, P Whyte, M Bloch, M H Shokeir, H Soltan, W Meschino, A Summers, O Suchowersky, J P Welch. J Med Genet 1993
75
12

Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington disease.
M Huggins, M Bloch, S Kanani, O W Quarrell, J Theilman, A Hedrick, B Dickens, A Lynch, M Hayden. Am J Hum Genet 1990
56
16

Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.
B B Biesecker, M Boehnke, K Calzone, D S Markel, J E Garber, F S Collins, B L Weber. JAMA 1993
249
9

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
598
9

Social system responses to Huntington disease.
S Kessler, M Bloch. Fam Process 1989
53
16

Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
74
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.